Previous close | 562.97 |
Open | 566.97 |
Bid | 569.33 x 1200 |
Ask | 569.84 x 1000 |
Day's range | 563.66 - 571.15 |
52-week range | 475.77 - 618.36 |
Volume | |
Avg. volume | 1,424,680 |
Market cap | 223.677B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 28.70 |
EPS (TTM) | 19.87 |
Earnings date | 26 Apr 2023 - 01 May 2023 |
Forward dividend & yield | 1.20 (0.21%) |
Ex-dividend date | 14 Dec 2022 |
1y target est | 646.12 |
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $562.97, marking a +1.41% move from the previous day.
Thermo Fisher's (TMO) latest collaboration with ArsenalBio supports the latter's clinical manufacturing of autologous T-cell therapies for advanced cancer treatment.
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.